Airfinity provides real-time mapping on the global antiviral landscape to PAD initiative

Posted on Sep 14, 2022

Airfinity is proud to be working with Pandemic Antiviral Discovery (PAD) initiative to provide real-time mapping on the global antiviral landscape, a critical part of the world's response to viral threats.

PAD is a joint initiative between Novo Nordisk Foundation, Open Philanthropy and Bill & Melinda Gates Foundation, founded to catalyse the discovery and early development of antiviral medicines for the next pandemic and, ultimately, save lives.

Airfinity tracks and analyses over 500 antiviral candidates across 3 pathogen families (coronaviridae, paramyxovirus and orthomyxovirus), most of which are currently in development for SARS-CoV-2 treatment, in addition to Influenza and Nipah.

Our detailed analysis into research, development and the funding landscape helps decision makers get answers to time-sensitive and critical questions, including: → Which government agencies and nonprofit organisations are investing heavily in antiviral research and procurement for viruses of pandemic potential? → Which countries and organisations/funding bodies are ranking the highest for antiviral research performance? → Which antiviral target are being investigated across different viral pathogens? → What are the key drives of antiviral demand and uptake?

Get in touch to learn more about our work with antivirals and get a free briefing with our Therapeutics Lead.

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022